Literature DB >> 6981383

Pseudomonas infection, allergy, and cystic fibrosis.

R W Pitcher-Wilmott, R J Levinsky, I Gordon, M W Turner, D J Matthew.   

Abstract

The clinical significance of the high prevalence of positive immediate skin tests in cystic fibrosis is unclear. Using analysis of variance, we have tested the hypothesis that patients with allergic cystic fibrosis have worse lung disease than non-allergic patients. Clinical data, skin prick tests, total or specific IgE antibody levels, chest radiographs, and pulmonary function tests were obtained in 104 cystic fibrosis patients. Patients with positive immediate skin reactions to at least one allergen were more likely to be persistently colonised by Pseudomonas aeruginosa than skin test negative patients. The skin test positive patients were also significantly older (mean difference 2.15 years). Analysis of variance showed that pseudomonas infection was the most significant factor contributing to lung damage and the effect of allergy was not significant. Similar longitudinal analysis of pulmonary function over 5 years and study of the hospital admission rate showed that the only statistically significant factor associated with deterioration was colonisation with P. aeruginosa.

Entities:  

Mesh:

Year:  1982        PMID: 6981383      PMCID: PMC1627714          DOI: 10.1136/adc.57.8.582

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Lung function in childhood. I. The forced expiratory volumes in healthy children using a spirometer and reverse plethysmograph.

Authors:  J J Cogswell; D Hull; A D Milner; A P Norman; B Taylor
Journal:  Br J Dis Chest       Date:  1975-01

2.  The systematic evaluation of the chest radiograph in cystic fibrosis.

Authors:  A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1974

3.  Role of house-dust mites in childhood asthma.

Authors:  J K Sarsfield
Journal:  Arch Dis Child       Date:  1974-09       Impact factor: 3.791

4.  Radioimmunosorbent assay of allergens.

Authors:  M Ceska; R Eriksson; J M Varga
Journal:  J Allergy Clin Immunol       Date:  1972-01       Impact factor: 10.793

5.  Aspergillus antibody in patients with cystic fibrosis.

Authors:  E J Bardana; K L Sobti; F D Cianciulli; M J Noonan
Journal:  Am J Dis Child       Date:  1975-10

Review 6.  Immediate skin-test reactivity in a general population sample.

Authors:  R A Barbee; M D Lebowitz; H C Thompson; B Burrows
Journal:  Ann Intern Med       Date:  1976-02       Impact factor: 25.391

Review 7.  The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

8.  Coexistent respiratory allergy and cystic fibrosis.

Authors:  G S Rachelefsky; A Osher; R E Dooley; B Ank; E R Stiehm
Journal:  Am J Dis Child       Date:  1974-09

9.  Cystic fibrosis, atopy, and airways lability.

Authors:  M Silverman; F D Hobbs; I R Gordon; F Carswell
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

10.  Aspergillosis and atopy in cystic fibrosis.

Authors:  L A Nelson; M L Callerame; R H Schwartz
Journal:  Am Rev Respir Dis       Date:  1979-10
View more
  15 in total

1.  Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.

Authors:  N M Byrne; P M Keavey; J D Perry; F K Gould; D A Spencer
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

2.  Allergy-important advances in clinical medicine: immunologic aspects of cystic fibrosis.

Authors:  E J Lee; D C Heiner
Journal:  West J Med       Date:  1984-10

3.  Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.

Authors:  M Wells; S L Gaffin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  Environmental allergies and respiratory morbidities in cystic fibrosis.

Authors:  Joseph M Collaco; Christopher B Morrow; Deanna M Green; Garry R Cutting; Peter J Mogayzel
Journal:  Pediatr Pulmonol       Date:  2012-11-09

Review 5.  Antibiotic hypersensitivity in patients with CF.

Authors:  Sujatha Ramesh
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

6.  Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  A Penketh; M E Hodson; H Gaya; J C Batten
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

7.  Cystic fibrosis and allergic bronchopulmonary aspergillosis.

Authors:  E J Simmonds; J M Littlewood; E G Evans
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 8.  The relationship between atopy and cystic fibrosis.

Authors:  R W Wilmott
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K.

Authors:  W Y Wong; R T Irvin; W Paranchych; R S Hodges
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725

10.  Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes.

Authors:  T F Bruno; D E Buser; R M Syme; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.